Lack of evidence for CDK12 as an ovarian cancer predisposing gene - Institut Curie Accéder directement au contenu
Article Dans Une Revue Familial Cancer Année : 2020

Lack of evidence for CDK12 as an ovarian cancer predisposing gene

Résumé

CDK12 variants were investigated as a genetic susceptibility to ovarian cancer in a series of 416 unrelated and consecutive patients with ovarian carcinoma and who carry neither germline BRCA1 nor BRCA2 pathogenic variant. The presence of CDK12 variants was searched in germline DNA by massive parallel sequencing on pooled DNAs. The lack of detection of deleterious variants and the observed proportion of missense variants in the series of ovarian carcinoma patients as compared with all human populations strongly suggests that CDK12 is not an ovarian cancer predisposing gene.

Domaines

Cancer
Fichier principal
Vignette du fichier
FAME-pdf.pdf (1.32 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-03036539 , version 1 (02-12-2020)

Identifiants

Citer

Alexandre Eeckhoutte, Mathilde Saint-Ghislain, Manon Reverdy, Virginie Raynal, Sylvain Baulande, et al.. Lack of evidence for CDK12 as an ovarian cancer predisposing gene. Familial Cancer, 2020, 19 (3), pp.203-209. ⟨10.1007/s10689-020-00169-2⟩. ⟨inserm-03036539⟩
149 Consultations
368 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More